Trademark Alertz ®
Search
Trademark
Owner
Trademark: ELLIPSES PHARMA 2072231
Word
ELLIPSES PHARMA
ID
2072231
Trademark Type
Word
Status
Registered: Registered/protected
Application Date
27 February 2020
Registration Date
27 February 2020
Renewal Date
27 February 2030
Owner(s)
Ellipses Pharma Ltd a United Kingdom company
Service
Spruson & Ferguson
Goods and Services:
Class 5
:
Pharmaceutical preparations
;
veterinary preparations
;
dietetic preparations for medical purposes
;
dietetic foods for use in clinical nutrition
;
food supplements
;
nutraceuticals for therapeutic or medical purposes
;
medicated food supplements
;
biological preparations for the treatment of cancer
;
anti-cancer preparations
;
anti-cancer drugs
;
compounds for treating cancer
;
biopharmaceuticals for the treatment of cancer
;
anti-cancer preparations of chemical origin
;
anti-cancer preparations of plant origin
;
anti-cancer preparations of microbial origin
;
pharmaceutical preparations for the treatment of cancer
;
anti-cancer preparations from hormones and antagonists
;
pharmaceutical preparations and substances for the prevention of cancer
;
pharmaceutical preparations and substances for the treatment of cancer
;
all of the aforesaid for use in oncology, surgical oncology, radiation therapy, chemotherapy, hormonal therapy, immunotherapy, radiotherapy, targeted cancer therapy, and the prevention, diagnosis, treatment, management of, and/or surgery in relation to cancer
;
Pharmaceutical preparations and veterinary preparations.
Class 42
:
Medical and pharmacological research services
;
biological research, clinical research and medical research
;
research and development for drug and pharmaceutical development provided by a network of experts
;
design, development and testing of drugs and pharmaceuticals provided by a network of experts
;
Providing scientific and technological services and research, analysis, and design relating thereto
;
design, development and testing of drugs and pharmaceuticals for the treatment and/or prevention of cancer
;
laboratory research into new drugs and pharmaceutical products
;
pharmaceutical drug development services
;
research relating into medicines
;
consultancy services relating to scientific and medical research
;
expert advice relating to drug development
;
laboratory analysis
;
scientific advisory services
;
scientific research projects and studies
;
conducting clinical trials
;
clinical research
;
clinical research for cancer treatments and pharmaceuticals
;
clinical trials provided online by a network of experts
;
conducting and collating of research for treatment, cure and/or prevention of cancer provided by a network of experts
;
development of measuring and testing methods
;
quality control services
;
evaluation of drug development services
;
industrial testing
;
pharmaceutical product evaluation
;
testing of chemicals.